{Reference Type}: Journal Article
{Title}: Case Commentary: When Voldemort Meets Sauron: Treatment Considerations for Emerging Dual-Carbapenemase-Producing Extensively Drug-Resistant Pseudomonas aeruginosa.
{Author}: Wangchinda W;Pogue JM;
{Journal}: Antimicrob Agents Chemother
{Volume}: 67
{Issue}: 7
{Year}: 2023 07 18
{Factor}: 5.938
{DOI}: 10.1128/aac.00475-23
{Abstract}: Infections caused by extensively drug-resistant Pseudomonas aeruginosa are difficult to treat due to limited effective treatment options. In this issue, a patient with a corneal infection caused by a Verona integron-encoded metallo-β-lactamase (VIM)- and Guiana extended-spectrum β-lactamase (GES)-coproducing P. aeruginosa strain associated with the recent artificial tears-related outbreak in the United States is described. This resistance genotype/phenotype further compromises therapeutic options, and this report provides insights into diagnostic and treatment approaches for clinicians dealing with infections due to this highly resistant P. aeruginosa.